Congressman Collins’s Deep Financial Ties to Biotech Firms Posed Other Conflicts by KATIE THOMAS and SHEILA KAPLAN

Mr. Collins, among the wealthiest members of Congress, has decided not to seek re-election in the wake of insider trading charges stemming from investments he and others had in a biotech firm.

Published: August 11, 2018 at 02:00AM

from #NYT Science Read the full article here: